Clinical significance and usefulness of soluble heparin binding-epidermal growth factor in gastric cancer

doi:10.3748/wjg.v21.i7.2080

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 7

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7032)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-7) series.

Item

Count

PDF

343

WORD

174

HTML

3230

Figures (1-1)

317

Tables (1-7)

306

Sum=4370

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1123

Download

1539

Sum=2662

Feb 21, 2015 (publication date) through Feb 18, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Gastroenterol. Feb 21, 2015; 21(7): 2080-2088
Published online Feb 21, 2015. doi: 10.3748/wjg.v21.i7.2080

Table 6 Pearson’s correlation between serum soluble heparin-binding epidermal growth factor-like growth factor and age in non-cancer groups vs cancer groups

Groups		Serum sHB-EGF	Serum CEA
Groups		γ_p (P value)	γ_p (P value)
Non-cancer groups¹	Age	-0.108 (0.313)	0.122 (0.265)
Cancer groups²	Age	-0.314 (0.010)	-0.187 (0.133)

¹Non-cancer groups include normal/gastritis and IM/dysplasia groups.

²Cancer groups include EGC and AGC groups. γ_p: Pearson’s correlation coefficient. Statistically significant values are given in bold print. AGC: Advanced gastric cancer; EGC: Early gastric cancer; sHB-EGF: Soluble heparin-binding epidermal growth factor-like growth factor; CEA: Carcinoembryonic antigen.

Citation: Chung HW, Kong HY, Lim JB. Clinical significance and usefulness of soluble heparin binding-epidermal growth factor in gastric cancer. World J Gastroenterol 2015; 21(7): 2080-2088
URL: https://www.wjgnet.com/1007-9327/full/v21/i7/2080.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i7.2080